Amerisourcebergen: Here’s What Investors Need to Know Before Earnings

Amerisourcebergen (NYSE:ABC) will report earnings before markets open on Wednesday, July 24th. AmerisourceBergen Corporation is a pharmaceutical services company. The Company distributes pharmaceutical products and services. AmerisourceBergen distributes an offering of brand name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers.

Here is your Cheat Sheet to Amerisourcebergen Earnings:

Earnings Expectations: Analysts expect earnings of $0.74 per share on revenues of $21.33 billion. Currently, the company’s P/E ratio stands at 25.40.

Analyst Trends:

Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.74 to a profit $0.73. For the current year, the average estimate is a profit of $3.06, which is worse than the estimate ninety days ago.

Earnings Trends:

Here’s how Amerisourcebergen has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 70,190 71,760 77,954 80,218 79,490
Diluted EPS ($) 0.77 1.66 2.22 2.54 2.80

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012 Mar. 31, 2013
Revenue ($) in millions 19,769.38 19,452.97 21,466.31 20,523.67
Diluted EPS ($) 0.71 0.66 0.71 0.19

Past Performance:
Amerisourcebergen has beat analyst estimates 2 times in the past four quarters. This is not consistent enough to get bullish yet.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]